C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 17/08 (2006.01) A61K 31/70 (2006.01)
Patent
CA 2317131
The invention relates to novel erythromycin derivatives, particularly ones with novel C-13 R13 substituents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are useful as antibacterial agents and antiprotozoa agents and for other applications (e.g., anticancer, atherosclerosis, gastric motility reduction, etc.) in mammals, including man, as well as in fish and birds. The invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial protozoa infections by administering such compounds. The invention also relates to methods of preparing such compounds and to intermediates useful in such preparation.
L'invention concerne de nouveaux dérivés d'érythromycine, en particulier ceux avec de nouveaux substituants C-13 R<13>, ainsi que les sels pharmaceutiquement acceptables de ces dérivés. Les composés de cette invention sont utiles comme agents antibactériens et agents antiprotozoaires, ainsi que dans d'autres applications (par exemple pour lutter contre le cancer, l'athérosclérose, la baisse de la motilité gastrique, etc.) chez des mammifères, y compris l'homme, mais aussi chez les poissons et les oiseaux. L'invention concerne également des compositions pharmaceutiques renfermant ces composés, ainsi que des méthodes permettant de traiter des infections bactériennes ou des protozooses par administration de ces composés. L'invention concerne enfin des méthodes de préparation de ces composés et des produits intermédiaires utiles à cette préparation.
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Novel erythromycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel erythromycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel erythromycin derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1577333